Salem Investment Counselors’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Salem Investment Counselors’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-375	Closed	-$8K	–	1141
2021 Q3	$8K	Buy	+375	New	+$10.4K	﹤0.01%	805

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Salem Investment Counselors's DRNA Position: Q4 2021 in Review

Salem Investment Counselors sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 375 shares — an estimated $8K sold.

Salem Investment Counselors first reported a position in DRNA in Q3 2021 and held it in 1 quarter. The position peaked at $8K in Q3 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

Salem Investment Counselors reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Salem Investment Counselors sold 375 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $8K.
Salem Investment Counselors first reported a position in Dicerna Pharmaceuticals, Inc. in Q3 2021 and held it in 1 quarter.
Salem Investment Counselors's Dicerna Pharmaceuticals, Inc. position peaked at $8K in Q3 2021.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on Salem Investment Counselors's 13F filing for Q4 2021, filed 15 Feb 2022.